热门资讯> 正文
帕拉丁科技公司定价1580万美元公开募股，资助肥胖计划
2025-11-06 22:02
- Palatin Technologies (OTC:PTNT) priced an underwritten public offering of 2.43M shares (or pre-funded warrants) at a combined price of $6.50/unit.
- Each unit includes one share (or pre-funded warrant), one Series J Warrant, and one Series K Warrant, each to purchase one share.
- Series J Warrants: exercisable at $6.50, expire 18 months after issuance or 31 days after FDA acceptance of Palatin’s obesity IND.
- Series K Warrants: exercisable at $8.125, expire in five years, but terminate early if the corresponding Series J Warrants remain unexercised after the FDA period.
- Gross proceeds expected at ~$15.8M, with a 45-day option for underwriters to buy 364,615 additional shares.
- Closing expected November 12, 2025.
- Proceeds will fund Palatin’s obesity drug development, along with working capital and general corporate purposes.
More on Palatin Technologies
- Seeking Alpha’s Quant Rating on Palatin Technologies
- Financial information for Palatin Technologies
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
